Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

857 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Active, Not Recruiting

A Study of KT-621 Administered Orally to Participants With Moderate to Severe Atopic Dermatitis

NCT07217015

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Kymera Investigative Site Birmingham, Alabama, United States
  • Kymera Investigative Site North Little Rock, Arkansas, United States
  • Kymera Investigative Site Freemont, California, United States
  • Kymera Investigative Site Los Angeles, California, United States
View all 68 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Chungnam National University Hospital Daejeon, Chungcheongnam-do, South Korea
  • Korea University AnSan Hospital Ansan, Gyeonggi-do, South Korea
  • Chung-Ang University Hospital Seoul, Seoulteukbyeolsi, South Korea
  • Kyunghee University Medical Center Seoul, Seoulteukbyeolsi, South Korea
View Trial Details
Active, Not Recruiting

A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis

NCT06832618

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • Saguaro Dermatology Phoenix, Arizona, United States
  • National Jewish Health Denver, Colorado, United States
  • Encore Medical Research, Llc Hollywood Hollywood, Florida, United States
View all 93 locations
View Trial Details
Active, Not Recruiting

An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis

NCT07027527

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Investigational Site Darlinghurst, New South Wales, Australia
  • Investigational Site Kogarah, New South Wales, Australia
  • Investigational Site Westmead, New South Wales, Australia
  • Investigational Site Woolloongabba, Queensland, Australia
View all 20 locations
View Trial Details
Active, Not Recruiting

Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)

NCT02612454

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +10 more
Locations
  • Regeneron Investigational Site Birmingham, Alabama, United States
  • Regeneron Investigational Site Gilbert, Arizona, United States
  • Regeneron Investigational Site Bakersfield, California, United States
  • Regeneron Investigational Site Long Beach, California, United States
View all 84 locations
View Trial Details
Active, Not Recruiting

Systems Biology of Early Atopy

NCT04798079

Conditions
Allergic Diseases, Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +12 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Sean N. Parker Center for Allergy & Asthma Research at Stanford University Stanford, California, United States
  • National Jewish Health Denver, Colorado, United States
  • Northwestern University Feinberg School of Medicine: Dept of Dermatology Chicago, Illinois, United States
View all 13 locations
View Trial Details
Active, Not Recruiting

A Study to See How Well Lebrikizumab Works in Adults and Adolescents With Moderate Atopic Dermatitis (Eczema) and High Itch Burden

NCT07006792

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Total Skin & Beauty Dermatology Center, PC DBA Total Dermatology Birmingham, Alabama, United States
  • Research Solutions of Arizona Litchfield Park, Arizona, United States
  • Alliance Dermatology and Mohs Center Phoenix, Arizona, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis

NCT07220577

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Ctr for Dermatology Clinical Res Fremont, California, United States
  • Aesthetics Skin Care Dermatologic Surgery Rockville, Maryland, United States
  • Care Access Hoboken Hoboken, New Jersey, United States
  • Novartis Investigative Site Pleven, Bulgaria
View all 28 locations
View Trial Details

Related conditions